Back to results
US 2025/0049768 A1Published application
Methods of treating estrogen receptor-associated diseases
AssigneeOlema Pharmaceuticals, Inc.
InventorsCyrus L. Harmon, Peter J. Kushner, David C. Myles, Leslie Hodges Gallagher
Life of this patent
Estimating the term…
Abstract
The present disclosure provides methods of treating a disease, disorder, or condition associated with ER+/HER2+ cancer using Compound 1, or a pharmaceutically acceptable salt thereof.
Claims38
A method of treating cancer in a subject determined to have an ER+ and HER2+ cancer, the method comprising:
- administering to the subject Compound 1:
- or a pharmaceutically acceptable salt thereof.
In a method of treating cancer in a subject determined to have an ER+ and HER2+ cancer, the improvement comprising administering to the subject Compound 1:
- or a pharmaceutically acceptable salt thereof.
In a method of treating ER+ cancer comprising administering Compound 1:
- or a pharmaceutically acceptable salt thereof,
- the improvement comprising administering Compound 1 or a pharmaceutically acceptable salt thereof to a subject determined to have an ER+ and HER2+ cancer.
Dependencies are inferred from the claim text.